GB0319708D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0319708D0
GB0319708D0 GB0319708A GB0319708A GB0319708D0 GB 0319708 D0 GB0319708 D0 GB 0319708D0 GB 0319708 A GB0319708 A GB 0319708A GB 0319708 A GB0319708 A GB 0319708A GB 0319708 D0 GB0319708 D0 GB 0319708D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0319708A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0319708A priority Critical patent/GB0319708D0/en
Priority to JP2004571743A priority patent/JP2006503108A/en
Priority to AU2003285300A priority patent/AU2003285300B2/en
Priority to PL03375993A priority patent/PL375993A1/en
Priority to NZ538515A priority patent/NZ538515A/en
Priority to AT03778283T priority patent/ATE442367T1/en
Priority to BR0314392-9A priority patent/BR0314392A/en
Priority to US10/527,866 priority patent/US20060089375A1/en
Priority to SI200331680T priority patent/SI1539753T1/en
Priority to CA002497550A priority patent/CA2497550A1/en
Priority to PCT/EP2003/011814 priority patent/WO2004024728A2/en
Priority to ES03778283T priority patent/ES2331119T3/en
Priority to DK03778283T priority patent/DK1539753T3/en
Priority to MXPA05002887A priority patent/MXPA05002887A/en
Priority to KR1020057004514A priority patent/KR20050052501A/en
Priority to DE60329193T priority patent/DE60329193D1/en
Priority to PT03778283T priority patent/PT1539753E/en
Priority to EP03778283A priority patent/EP1539753B1/en
Priority to ARP030103311 priority patent/AR041195A1/en
Priority to CNB038250438A priority patent/CN100387598C/en
Priority to MYPI20033510 priority patent/MY135776A/en
Priority to TW92125497A priority patent/TWI283678B/en
Publication of GB0319708D0 publication Critical patent/GB0319708D0/en
Priority to IL166898A priority patent/IL166898A/en
Priority to NO20050841A priority patent/NO20050841L/en
Priority to IS7709A priority patent/IS7709A/en
Priority to MA28224A priority patent/MA27475A1/en
Priority to US12/013,529 priority patent/US20080175914A1/en
Priority to CY20091101212T priority patent/CY1109619T1/en
Priority to AU2010201417A priority patent/AU2010201417A1/en
Ceased legal-status Critical Current

Links

GB0319708A 2002-09-16 2003-08-21 Compounds Ceased GB0319708D0 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
GB0319708A GB0319708D0 (en) 2003-08-21 2003-08-21 Compounds
DE60329193T DE60329193D1 (en) 2002-09-16 2003-09-12 PYRAZOLO (3,4-B) PYRIDINE COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASINHIBITORS
PT03778283T PT1539753E (en) 2002-09-16 2003-09-12 Pyrazolo(3,4-b)pyridine compounds, and their use as phosphodiesterase inhibitors
AU2003285300A AU2003285300B2 (en) 2002-09-16 2003-09-12 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
NZ538515A NZ538515A (en) 2002-09-16 2003-09-12 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
AT03778283T ATE442367T1 (en) 2002-09-16 2003-09-12 PYRAZOLO(3,4-B)PYRIDINE COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
BR0314392-9A BR0314392A (en) 2002-09-16 2003-09-12 Compound or salt thereof, pharmaceutical composition, use of a compound, method of treatment and / or prophylaxis of an inflammatory and / or allergic disease or cognitive impairment in a mammal, and, combination
US10/527,866 US20060089375A1 (en) 2002-09-16 2003-09-12 Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
SI200331680T SI1539753T1 (en) 2002-09-16 2003-09-12 Pyrazolo(3,4-b)pyridine compounds, and their use as phosphodiesterase inhibitors
CA002497550A CA2497550A1 (en) 2002-09-16 2003-09-12 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
PCT/EP2003/011814 WO2004024728A2 (en) 2002-09-16 2003-09-12 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
ES03778283T ES2331119T3 (en) 2002-09-16 2003-09-12 PIRAZOLO COMPOUNDS (3,4-B) PIRIDINE, AND ITS USE AS PHOSPHODESTERASE INHIBITORS.
DK03778283T DK1539753T3 (en) 2002-09-16 2003-09-12 Pyrazolo (3,4B9 pyridine compounds and their use as phosphodiesterase inhibitors)
MXPA05002887A MXPA05002887A (en) 2002-09-16 2003-09-12 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors.
KR1020057004514A KR20050052501A (en) 2002-09-16 2003-09-12 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
JP2004571743A JP2006503108A (en) 2002-09-16 2003-09-12 Pyrazolo [3,4-b] pyridine compounds and their use as phosphodiesterase inhibitors
PL03375993A PL375993A1 (en) 2002-09-16 2003-09-12 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
EP03778283A EP1539753B1 (en) 2002-09-16 2003-09-12 Pyrazolo(3,4-b)pyridine compounds, and their use as phosphodiesterase inhibitors
ARP030103311 AR041195A1 (en) 2002-09-16 2003-09-12 PIRAZOLO COMPOUNDS [3,4] PIRIDINE, AND ITS USE AS PHOSPHODESTERASE INHIBITORS
CNB038250438A CN100387598C (en) 2002-09-16 2003-09-12 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
MYPI20033510 MY135776A (en) 2002-09-16 2003-09-15 PYRAZOLO [3,4-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
TW92125497A TWI283678B (en) 2002-09-16 2003-09-16 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
IL166898A IL166898A (en) 2002-09-16 2005-02-15 Pyrazolo[3,4-b]pyridine compounds and their use as phosphodiesterase inhibitors
NO20050841A NO20050841L (en) 2002-09-16 2005-02-16 Pyrazolo [3,4-B] pyridine compounds and their use as phosphodiesterase inhibitors
IS7709A IS7709A (en) 2002-09-16 2005-02-24 Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
MA28224A MA27475A1 (en) 2002-09-16 2005-04-15 PYRAZOLO [3,4-B] PYRIDINE COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
US12/013,529 US20080175914A1 (en) 2002-09-16 2008-01-14 Pyrazolo[3,4-b]Pyridine Compounds, and their Use as Phosphodiesterase Inhibitors
CY20091101212T CY1109619T1 (en) 2002-09-16 2009-11-24 PYRAZOLO COMPOUNDS [3,4-b] PYRIDINES AND THEIR USE AS PHOSPHOSTERATION INSPECTORS
AU2010201417A AU2010201417A1 (en) 2002-09-16 2010-04-08 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0319708A GB0319708D0 (en) 2003-08-21 2003-08-21 Compounds

Publications (1)

Publication Number Publication Date
GB0319708D0 true GB0319708D0 (en) 2003-09-24

Family

ID=28460098

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0319708A Ceased GB0319708D0 (en) 2002-09-16 2003-08-21 Compounds

Country Status (1)

Country Link
GB (1) GB0319708D0 (en)

Similar Documents

Publication Publication Date Title
GB0309781D0 (en) Compounds
GB0316915D0 (en) Compounds
GB0315950D0 (en) Compounds
GB0327761D0 (en) Compounds
GB0305559D0 (en) Compounds
GB0317268D0 (en) Compounds
GB0314476D0 (en) Compounds
GB0314479D0 (en) Compounds
GB0314478D0 (en) Compounds
GB0304665D0 (en) Compounds
GB0305553D0 (en) Compounds
GB0313915D0 (en) Compounds
GB0306329D0 (en) Compounds
GB0313914D0 (en) Compounds
GB0302512D0 (en) Compounds
GB0304494D0 (en) Compounds
GB0317269D0 (en) Compounds
GB0301916D0 (en) Compounds
GB0310851D0 (en) Compounds
GB0317141D0 (en) Compounds
GB0300298D0 (en) Compounds
GB0316865D0 (en) Compounds
GB0301719D0 (en) Compounds
GB0314698D0 (en) Compounds
GB0314477D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)